<p><strong>The recommended starting dosage of Dasatinib for</strong>:</p>

<ul>
	<li>Chronic phase CML is 100 mg administered orally once daily.</li>
	<li>Accelerated phase CML, myeloid or lymphoid blast phase CML, or Ph+ ALL is 140 mg administered orally once daily.</li>
</ul>

<p>Tablets should not be crushed or cut; they should be swallowed whole. Dasatinib can be taken with or without a meal, either in the morning or in the evening.<br />
<br />
In clinical studies, treatment with Dasatinib was continued until disease progression or until no longer tolerated by the patient. The effect of stopping treatment on long-term disease outcome after the achievement of a cytogenetic response (including complete cytogenetic response [CCyR]) or major molecular response (MMR) is not known.</p>